ALBANY, N.Y., March 2, 2021 /PRNewswire/ -- Lyophilization is a crucial process for injectable for achieving a stable drug product and in ensuring an adequate biological activity. The process regulates numerous key drug product quality attributes such as the cake stability during storage and transportation. A majority of biopharmaceutical such as proteins, vaccines, antibodies, enzymes, biologics, peptides, and plasma need to undergo adequate lyophilisation before commercialization. The process is also being used for some diagnostic reagents, especially those used in IVD. Types of packaging used for lyophilized injectable drugs are single-use vials, point-of-care reconstitution, and specialty packaging, with single-use vials are expected to witness vast opportunity during the forecast period of 2018 – 2026.
The lyophilized injectable drugs market has seen a growing array of processes that affect different parameters at each drug development stage. Outsourcing of these services has thus gained a huge impetus from the growing number of contract research manufacturing services (CRAMS).
The lyophilized injectable drugs market stood at US$ 2,300 Mn in 2017 and is slated to rise at CAGR of 6.7% from 2018 to 2026.
Key Findings of Lyophilized Injectable Drugs Market Study
Advances in Biopharmaceuticals Formulation Present Vast Potential
Incredible strides that biopharmaceuticals manufacturing has made in the drug-making industry present a vast scope for the commercialization of formulations in the lyophilized injectable drugs market. Need for improving the stability of biopharmaceuticals has led to continuous advances in the formulation, notably for proteins. New approaches have come to the core to support these initiatives. A key trend spurring biopharmaceuticals manufacturing is the rise in number of contract research manufacturing services (CRAMS). Growing demand for biologics and protein-based therapeutics for treating diseases has cemented investments in CRAMs.
Need for Improving Biological Activities of Drugs for Metabolic Disorders and Infectious Diseases Advancing Growth
The growing prevalence of metabolic disorders and rise in incidence of infectious diseases in the past few decades have nudged pharma companies to enrich their drug pipeline. This has spurred the development of numerous lyophilized injectable drugs. Further, need for improving their biological activity has led to the demand for novel processes and the adoption of new lyophilizer designs. A case in point is lyophilization of small-molecule injectables. Need for improving the stability of some diagnostic reagents has also bolstered the demand for lyophilized products with high biological and chemical activity.
North America led the global market in 2017 and is anticipated to witness substantial revenue generation in coming few years as well. The prevalence of chronic diseases has spurred research on biopharmaceuticals. Increasing spending on contract research manufacturing services is also boosting the market.
On the other hand, in recent years, Asia Pacific has seen rapidly expanding avenues for lyophilized injectable drugs market. Continuously improving healthcare services have bolstered the revenue potential for drug making companies. Sizable opportunities are likely to come from India, China, Indonesia, Malaysia, and Singapore.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."